Biopsy Devices Market Overview

An overview of conceptual frameworks, analytical approaches of the biopsy devices market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market. Biopsy devices market is expected to grow with significant rate in the near future.

The global biopsy devices market in 2020 is estimated for more than US$ 1.4 Bn and expected to reach a value of US$ 3.3 Bn by 2028 with a significant CAGR of 6.7%.

Biopsy Devices Market Definition

A biopsy involves taking small samples from the body including from sites such as skin, organs, and other structures so that it can be examined under microscopy and for histological examinations. The biopsy may be needed in case of investigation of functional or structural abnormalities which helps diagnose the abnormal or diseased condition.

Biopsy devices are needed to perform a biopsy of a particular organ or tissue. A specific type of biopsy device is needed based on the indication or site from which the sample is to be taken. Heightening the importance of accurate diagnostic procedures for chronic diseases such as cancer drives demand for biopsy devices in the global market.

Biopsy Devices Market Dynamics

The growing incidence of cancer is the foremost factor driving the growth of the global biopsy devices market. According to Cancer Research U.K., 357,000 new cases of cancer were diagnosed in the U.K. in 2014, and the incidence rate is expected to increase by 2% every year by 2035. This growth in incidence clearly indicates the rising demand for biopsy devices in the nearest future. The market for biopsy devices is expected to witness a rapid rise due to a growing number of hospitals and diagnostic centers in emerging markets of the Asia Pacific and Latin America. The global biopsy devices market report includes market estimates and trends by device types, indication, and geography.

Besides, the growing demand for minimally invasive procedures is expected to expand the need for biopsy devices in hospitals and diagnostic centers over the forecast period of 2019-2027. According to Eurostat surgical operation and procedures statistics, the biopsy is the second most common diagnostic procedure for cancer diagnostics in Europe.

A breast biopsy is frequently performed among all types of biopsies and as per a population-based study performed by Mayo Clinic, the overall utilization rate for breast biopsy was found to be 62.6 per 10,000 women.

Biopsy Devices Market Key Players

The biopsy devices market is mainly dominated by C. R. Bard Inc., Becton, Dickinson and Company, INRAD Inc., Cook Group Incorporated, B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic Inc., Devicor Medical Products, Inc., and Hologic Inc.

Biopsy Devices Market Segmentation

The global biopsy devices market is segmented on the basis of devices, indication, and region. On the basis of devices, the global biopsy devices market can be segmented into breast biopsy devices, Core needle biopsy devices, fine needle aspiration biopsy devices, gastrointestinal biopsy devices, and robotic guidance systems. On the basis of indication, the global biopsy devices market can be segmented into breast cancer, gastrointestinal cancer, cervical cancer, lung cancer, and others.

The global biopsy devices market is expected to increase at a steady CAGR over the forecast period owing to the increasing chronic diseases, geriatric population, and increase in trend for immediate relief across the healthcare receivers.

Biopsy Devices Market Regional Overview and Analysis

On the basis of region, the global biopsy devices market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America biopsy devices market is expected to be the most dominating market throughout the forecast period. The presence of key players and increasing healthcare expenditure in the region are some of the revenue-boosting factors.

MMC Overview on Biopsy Devices Market Report

The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Biopsy Devices market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market. The report is titled as ‘Biopsy Devices Market: Opportunity Analysis and Future Assessment 2020-2028’.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Biopsy Devices

•    Advantage of Biopsy Devices over other modalities

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.

1.    Global Biopsy Devices Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Biopsy Devices Overview

2.1.    Introduction

2.1.1.    Market Definition

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Biopsy Devices Snapshot

2.4.    Global Biopsy Devices Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Biopsy Devices Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Biopsy Devices, By Devices

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Devices

3.1.2.    BPS Analysis, By Devices

3.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Devices

3.2.1.    Breast Biopsy Devices

3.2.2.    Core Needle Biopsy Devices

3.2.3.    Fine Needle Aspiration Biopsy Devices

3.2.4.    Gastro Intestinal Biopsy Devices

3.2.5.    Robotic Guidance Systems

3.3.    Global Biopsy Devices Attractiveness Index, By Devices

4.    Global Biopsy Devices, By Indication

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Indication

4.1.2.    BPS Analysis, By Indication

4.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Indication

4.2.1.    Breast Cancer

4.2.2.    Gastrointestinal Cancer

4.2.3.    Cervical Cancer

4.2.4.    Lung Cancer

4.2.5.    Others

4.3.    Global Biopsy Devices Attractiveness Index, By Indication

5.    Global Biopsy Devices, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East and Africa

5.3.    Global Biopsy Devices Attractiveness Index, By Region

6.    North America Biopsy Devices Analysis and Forecast, 2020–2028

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Country

6.2.1.    U.S. Biopsy Devices

6.2.2.    Canada Biopsy Devices

6.3.    North America Biopsy Devices, By Devices

6.3.1.    Breast Biopsy Devices

6.3.2.    Core Needle Biopsy Devices

6.3.3.    Fine Needle Aspiration Biopsy Devices

6.3.4.    Gastro Intestinal Biopsy Devices

6.3.5.    Robotic Guidance Systems

6.4.    North America Biopsy Devices, By Indication

6.4.1.    Breast Cancer

6.4.2.    Gastrointestinal Cancer

6.4.3.    Cervical Cancer

6.4.4.    Lung Cancer

6.4.5.    Others

6.5.    North America Biopsy Devices Attractiveness Index

6.5.1.    By Country

6.5.2.    By Devices

6.5.3.    By Indication

7.    Latin America Biopsy Devices Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

7.2.1.    Brazil Biopsy Devices

7.2.2.    Mexico Biopsy Devices

7.2.3.    Argentina Biopsy Devices

7.2.4.    Rest of Latin America Biopsy Devices

7.3.    Latin America Biopsy Devices, By Devices

7.3.1.    Breast Biopsy Devices

7.3.2.    Core Needle Biopsy Devices

7.3.3.    Fine Needle Aspiration Biopsy Devices

7.3.4.    Gastro Intestinal Biopsy Devices

7.3.5.    Robotic Guidance Systems

7.4.    Latin America Biopsy Devices, By Indication

7.4.1.    Breast Cancer

7.4.2.    Gastrointestinal Cancer

7.4.3.    Cervical Cancer

7.4.4.    Lung Cancer

7.4.5.    Others

7.5.    Latin America Biopsy Devices Attractiveness Index

7.5.1.    By Country

7.5.2.    By Devices

7.5.3.    By Indication

8.    Europe Biopsy Devices Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

8.2.1.    U.K. Biopsy Devices

8.2.2.    Germany Biopsy Devices

8.2.3.    Italy Biopsy Devices

8.2.4.    France Biopsy Devices

8.2.5.    Spain Biopsy Devices

8.2.6.    Russia Biopsy Devices

8.2.7.    Poland Biopsy Devices

8.2.8.    BENELUX Biopsy Devices

8.2.9.    NORDIC Biopsy Devices

8.2.10.    Rest of Europe Biopsy Devices

8.3.    Europe Biopsy Devices, By Devices

8.3.1.    Breast Biopsy Devices

8.3.2.    Core Needle Biopsy Devices

8.3.3.    Fine Needle Aspiration Biopsy Devices

8.3.4.    Gastro Intestinal Biopsy Devices

8.3.5.    Robotic Guidance Systems

8.4.    Europe Biopsy Devices, By Indication

8.4.1.    Breast Cancer

8.4.2.    Gastrointestinal Cancer

8.4.3.    Cervical Cancer

8.4.4.    Lung Cancer

8.4.5.    Others

8.5.    Europe Biopsy Devices Attractiveness Index

8.5.1.    By Country

8.5.2.    By Devices

8.5.3.    By Indication

9.    Asia Pacific Biopsy Devices Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

9.2.1.    China Biopsy Devices

9.2.2.    India Biopsy Devices

9.2.3.    Japan Biopsy Devices

9.2.4.    Australia and New Zealand Biopsy Devices

9.2.5.    South Korea Biopsy Devices

9.2.6.    ASEAN Biopsy Devices

9.2.7.    Rest of Asia Pacific Biopsy Devices

9.3.    Asia Pacific Biopsy Devices, By Devices

9.3.1.    Breast Biopsy Devices

9.3.2.    Core Needle Biopsy Devices

9.3.3.    Fine Needle Aspiration Biopsy Devices

9.3.4.    Gastro Intestinal Biopsy Devices

9.3.5.    Robotic Guidance Systems

9.4.    Asia Pacific Biopsy Devices, By Indication

9.4.1.    Breast Cancer

9.4.2.    Gastrointestinal Cancer

9.4.3.    Cervical Cancer

9.4.4.    Lung Cancer

9.4.5.    Others

9.5.    Asia Pacific Biopsy Devices Attractiveness Index

9.5.1.    By Country

9.5.2.    By Devices

9.5.3.    By Indication

10.    Middle East Biopsy Devices, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

10.2.1.    GCC Countries Biopsy Devices

10.2.2.    Israel Biopsy Devices

10.2.3.    Oman Biopsy Devices

10.2.4.    Rest of Middle East Biopsy Devices

10.3.    Middle East Biopsy Devices, By Devices

10.3.1.    Breast Biopsy Devices

10.3.2.    Core Needle Biopsy Devices

10.3.3.    Fine Needle Aspiration Biopsy Devices

10.3.4.    Gastro Intestinal Biopsy Devices

10.3.5.    Robotic Guidance Systems

10.4.    Middle East Biopsy Devices, By Indication

10.4.1.    Breast Cancer

10.4.2.    Gastrointestinal Cancer

10.4.3.    Cervical Cancer

10.4.4.    Lung Cancer

10.4.5.    Others

10.5.    Middle East Biopsy Devices Attractiveness Index

10.5.1.    By Country

10.5.2.    By Devices

10.5.3.    By Indication

11.    Africa Biopsy Devices, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

11.2.1.    South Africa Biopsy Devices

11.2.2.    Egypt Biopsy Devices

11.2.3.    North Africa Biopsy Devices

11.2.4.    Rest of Africa Biopsy Devices

11.3.    Africa Biopsy Devices, By Devices

11.3.1.    Breast Biopsy Devices

11.3.2.    Core Needle Biopsy Devices

11.3.3.    Fine Needle Aspiration Biopsy Devices

11.3.4.    Gastro Intestinal Biopsy Devices

11.3.5.    Robotic Guidance Systems

11.4.    Africa Biopsy Devices, By Indication

11.4.1.    Breast Cancer

11.4.2.    Gastrointestinal Cancer

11.4.3.    Cervical Cancer

11.4.4.    Lung Cancer

11.4.5.    Others

11.5.    Africa Biopsy Devices Attractiveness Index

11.5.1.    By Country

11.5.2.    By Devices

11.5.3.    By Indication

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    C. R. Bard, Inc

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Becton, Dickinson and Company 

13.3.3.    Cook Group Incorporated 

13.3.4.    Devicor Medical Products, Inc. (A Part of Leica Biosystems) 

13.3.5.    Argon Medical Devices, Inc. 

13.3.6.    B. Braun Melsungen AG 

13.3.7.    Cardinal Health, Inc. 

13.3.8.    Olympus Corporation 

13.3.9.    Boston Scientific Corporation 

13.3.10.    Fujifilm Holdings Corporation 

13.3.11.    Inrad, Inc. 

13.3.12.    Medtronic PLC

14.    Acronyms